tetrandrine has been researched along with Recrudescence in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Hirano, T; Wang, X; Wu, H; Xu, W; Yamada, H | 1 |
| Rossan, RN; Van Dyke, K; Ye, Z | 1 |
| Ao, ZF; Chen, BA; Gao, F; Shen, HL; Xia, W; Xu, WL; Zhang, YN | 1 |
1 trial(s) available for tetrandrine and Recrudescence
| Article | Year |
|---|---|
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia.
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Cytarabine; Daunorubicin; Etoposide; Flow Cytometry; Humans; Leukemia, Myeloid, Acute; Recurrence | 2006 |
2 other study(ies) available for tetrandrine and Recrudescence
| Article | Year |
|---|---|
Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.
Topics: Antineoplastic Agents; Benzylisoquinolines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Drug Synergism; Humans; Methylprednisolone; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Signal Transduction | 2020 |
Effective treatment with a tetrandrine/chloroquine combination for chloroquine-resistant falciparum malaria in Aotus monkeys.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Benzylisoquinolines; Chloroquine; Disease Models, Animal; Drug Resistance; Drug Therapy, Combination; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Recurrence; Treatment Outcome | 2013 |